异常或不可报告的 NIPT 结果的自然史和评估及其与母体肿瘤的关联-猫眼课题宝

异常或不可报告的 NIPT 结果的自然史和评估及其与母体肿瘤的关联

批准号：

10022465

负责人：

Diana Bianchi

金额：

$5.86万

依托单位：

NATIONAL HUMAN GENOME RESEARCH INSTITUTE

依托单位国家：

美国

项目类别：

财政年份：

资助国家：

美国

项目状态：

未结题

起止时间：

至

来源：

https://reporter.nih.gov/project-details/10022465

关键词：

Amniocentesis Aneuploidy Biochemistry Biocompatible Materials Biological Blood Blood Circulation Case Study Chorionic Villi Sampling Chromosomes Clinical DNA analysis DNA sequencing Data Detection Diagnosis Diagnostic Diagnostic tests Enrollment Ensure Evaluation Fetus Genetic Fingerprintings Genomics Guidelines Hematopoietic System Incidental Findings Institutional Review Boards Karyotype Laboratories Malignant Neoplasms Medical National Cancer Institute Natural History Neonatal Neoplasms Participant Patau&apos s syndrome Patients Physicians Placenta Plasma Positive Test Result Postpartum Period Predictive Value Pregnancy Pregnant Women Protocols documentation Provider Proxy Publishing Reporting Retrospective Studies Risk Sampling Serum Solid Neoplasm Suggestion Test Result Testing Time Ultrasonography United States National Institutes of Health Woman Work acronyms cell free DNA circulating DNA clinical Diagnosis clinical care clinical sequencing fetal follow-up genetic counselor meetings member multidisciplinary neoplastic cell prenatal prenatal testing

项目摘要

项目成果

Diana Bianchi的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Over the past year we have worked with the National Cancer Institute to develop a scientific protocol to study pregnant women who are identified as having noninvasive prenatal cell-free DNA sequencing results that are suggestive of malignancy as an incidental finding. The protocol was approved by the Scientific Review Board of the NCI and the NIH IRB. During FY 2019 we hired a genetic counselor/data coordinator who started on the project on August 19, 2019. Together with NCI, we are working through the details of the protocol to ensure that once patient enrollment begins it will occur smoothly. In addition, we have responded to multiple patient and provider inquiries regarding the study. The acronym for the study will be the IDENTIFY Study: Incidental Detection of Maternal Neoplasia Through Non-Invasive Cell Free DNA Analysis.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文